Table of Contents
ISRN Dermatology
Volume 2013, Article ID 852497, 7 pages
http://dx.doi.org/10.1155/2013/852497
Research Article

Possible Mechanisms by Which Topical 5-Fluorouracil and Dermabrasion Could Induce Pigment Spread in Vitiligo Skin: An Experimental Study

1Department of Dermatology, Saint-André Hospital, 33000 Bordeaux, France
2Department of Dermatology, Al-Minya University, Al-Minya 61111, Egypt
3Department of Pathology, Pellegrin Hospital, 33000 Bordeaux, France
4National Reference for Rare Skin Diseases, University Hospital, 33000 Bordeaux, France
5Department of Dermatology, Mohammed V Souissi University, Ibn Sina Hospital, 8007 Rabat, Morocco

Received 6 February 2013; Accepted 4 March 2013

Academic Editors: B. Amichai, C.-C. Lan, and E. Pasmatzi

Copyright © 2013 Y. Gauthier et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Parsad, R. Pandhi, S. Dogra, and B. Kumar, “Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches,” Journal of the American Academy of Dermatology, vol. 50, no. 1, pp. 63–67, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Tsuji and T. Hamada, “Topically administered fluorouracil in vitiligo,” Archives of Dermatology, vol. 119, no. 9, pp. 722–727, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Szekeres and M. Morvay, “Repigmentation of vitiligo macules treated topically with Efudix cream,” Dermatologica, vol. 171, no. 1, pp. 55–59, 1985. View at Google Scholar · View at Scopus
  4. B. Monk, “Topical fluorouracil in vitiligo,” Archives of Dermatology, vol. 121, no. 1, pp. 25–26, 1985. View at Google Scholar · View at Scopus
  5. S. Sethi, B. B. Mahajan, R. R. Gupta, and A. Ohri, “Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo,” International Journal of Dermatology, vol. 46, no. 8, pp. 875–879, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Anbar, W. Westerhof, A. Abdel-Rahman, M. El-Khayyat, and Y. El-Metwally, “Treatment of periungual vitiligo with Erbium-YAG-laser plus 5-flurouracil: a left to right comparative study,” Journal of Cosmetic Dermatology, vol. 5, no. 2, pp. 135–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. T. S. Anbar, W. Westerhof, A. T. Abdel-Rahman, A. A. Ewis, and M. A. El-Khayyat, “Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study,” Photodermatology Photoimmunology and Photomedicine, vol. 24, no. 6, pp. 322–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Garg, R. Chander, and A. Jain, “Combination of microdermabrasion and 5-Fluorouracil to induce repigmentation in vitiligo: an observational study,” Dermatologic Surgery, vol. 37, no. 12, pp. 1763–1766, 2011. View at Google Scholar
  9. T. Desai, C. L. Chen, A. Desai, and W. Kirby, “Basic pharmacology of topical imiquimod, 5-Fluorouracl and diclofenac for the dermatologic surgeon,” Dermatologic Surgery, vol. 38, pp. 97–103, 2012. View at Google Scholar
  10. D. L. Sachs, S. Kang, C. Hammerberg et al., “Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis,” Archives of Dermatology, vol. 145, no. 6, pp. 659–666, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Yen Moore, “Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders,” Journal of Dermatological Treatment, vol. 20, no. 6, pp. 328–335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. J. Dillaha, G. T. Jansen, and W. M. Honeycutt, “Selective cytotoxic effect of topical 5-Fluorouracil,” Archives of Dermatology, vol. 88, pp. 247–256, 1963. View at Google Scholar · View at Scopus
  13. D. S. Waldorf, M. L. Engel, and E. J. Van Scott, “Inhibition of wound epithelialization by topical 5-fluorouracil,” Archives of Dermatology, vol. 94, no. 6, pp. 786–789, 1966. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. Pujol, V. Rocamora, A. Lopez-Pousa, R. Taberner, and A. Alomar, “A rare local complication of intravenous 5-fluorouracil therapy,” Journal of the American Academy of Dermatology, vol. 39, no. 5, pp. 839–842, 1998. View at Google Scholar · View at Scopus
  15. R. Goyal, S. B. Chalamalaseth, K. Madan, and S. B. Paul, “5-Fluorouracil is associated with a peculiar skin reaction called “hand and foot syndrome”,” Indian Journal of Gastroenterology, vol. 26, no. 6, pp. 292–293, 2007. View at Google Scholar
  16. R. Rao and C. Balachandran, “A rare vasculo-cutaneous effect induced by systemic 5-fluorouracil,” Indian Journal of Dermatology, Venereology and Leprology, vol. 76, no. 6, pp. 714–715, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. C. Chan and S. J. Lin, “Serpentine supravenous hyperpigmentation,” New England Journal of Medicine, vol. 363, no. 5, article e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. E. R. C. Geddes and P. R. Cohen, “Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy,” Southern Medical Journal, vol. 103, no. 3, pp. 231–235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Van Tienhoven and J. W. Wilmink, “A woman with palmar and plantar hyperpigmentation,” Nederlands Tijdschrift voor Geneeskunde, vol. 155, no. 45, p. 4100, 2011. View at Google Scholar
  20. R. Tavares-Bello, “Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 10, pp. 1434–1435, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Tsuji and M. A. Karasek, “Differential effects of 5-fluorouracil on human skin melanocytes and malignant melanoma cells in vitro,” Acta Dermato-Venereologica, vol. 66, no. 6, pp. 474–478, 1986. View at Google Scholar · View at Scopus
  22. T. Tsuji and M. Karasek, “A procedure for the isolation of primary cultures of melanocytes from newborn and adult human skin,” Journal of Investigative Dermatology, vol. 81, no. 2, pp. 179–180, 1983. View at Google Scholar · View at Scopus
  23. Y. Gauthier, “An animal model applicable to vitiligo to study the marginal repigmentation pattern,” Pigment Cell Research, vol. 20, article 442, 2007. View at Google Scholar
  24. P. M. Cox, A. P. Dhillon, S. Howe, R. M. Pittilo, and J. Rode, “Repopulation of guinea-pig skin by melanocytes during wound healing: a morphometric study,” British Journal of Experimental Pathology, vol. 70, no. 6, pp. 679–689, 1989. View at Google Scholar · View at Scopus
  25. J. Dreßler, A. Busuttil, R. Koch, and D. J. Harrison, “Sequence of melanocyte migration into human scar tissue,” International Journal of Legal Medicine, vol. 115, no. 2, pp. 61–63, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. R. G. Staricco, “The melanocytes and the hair follicle,” Journal of Investigative Dermatology, vol. 35, pp. 185–194, 1960. View at Google Scholar
  27. R. G. Staricco, “Mechanism of migration of the melanocytes from the hair follicle into the epidermis following dermabrasion,” Journal of Investigative Dermatology, vol. 39, pp. 16–34, 1962. View at Google Scholar
  28. J. S. Pegum, “Dissociated depigmentation in vitiligo. Significance and therapeutic implication,” British Journal of Dermatology, vol. 67, pp. 348–350, 1955. View at Google Scholar
  29. J. E. Fulton, A. D. Rahimi, S. Mansoor, P. Helton, and P. Shitabata, “The treatment of hypopigmentation after skin resurfacing,” Dermatologic Surgery, vol. 30, no. 1, pp. 95–101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. H. L. Stoll and E. Klein, “Effect of occlusive dressing on the local administration of 5-fluorouracil to superficial basal cell carcinoma,” Journal of Investigative Dermatology, vol. 52, no. 3, pp. 304–306, 1969. View at Google Scholar · View at Scopus
  31. J. G. Morelli, J. J. Yohn, T. Zekman, and D. A. Norris, “Melanocyte movement in vitro: role of matrix proteins and integrin receptors,” Journal of Investigative Dermatology, vol. 101, no. 4, pp. 605–608, 1993. View at Google Scholar · View at Scopus
  32. J. G. Morelli, J. Kincannon, J. J. Yohn, T. Zekman, W. L. Weston, and D. A. Norris, “Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro,” Journal of Investigative Dermatology, vol. 98, no. 3, pp. 290–295, 1992. View at Google Scholar · View at Scopus
  33. J. G. Morelli, J. J. Yohn, M. B. Lyons, R. C. Murphy, and D. A. Norris, “Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes,” Journal of Investigative Dermatology, vol. 93, no. 6, pp. 719–722, 1989. View at Google Scholar · View at Scopus
  34. T. C. Lei, W. D. Vieira, and V. J. Hearing, “In vitro migration of melanoblasts requires matrix metalloproteinase-2: implications to vitiligo therapy by photochemotherapy,” Pigment Cell Research, vol. 15, no. 6, pp. 426–432, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. C. C. E. Lan, G. S. Chen, M. H. Chiou, C. S. Wu, C. H. Chang, and H. S. Yu, “FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo,” British Journal of Dermatology, vol. 153, no. 3, pp. 498–505, 2005. View at Publisher · View at Google Scholar · View at Scopus